CLSI and CLSA entrepreneur services and offerings connect life science startups to the resources needed to help them grow into the next generation of life sciences giants. Our programs create a platform for accessing the wealth of experience of Californian’s vibrant life sciences cluster, bringing our community together to connect, learn and network. We connect startups with potential business partners, investors, disease foundations, patient advocacy organizations, peers and other industry leaders.
CLSA Fellow Membership
Designed to nurture and grow new and incubator companies in California, CLSA Fellow membership allows qualifying life science startups to access the complete CLSA portfolio of benefits at a significantly reduced rate. Fellow membership allows early-stage companies to connect to and become a part of the most vibrant and experienced life science community in California and to access the collective purchasing power of the world’s largest life sciences cluster. In addition to enjoying significant savings through group purchasing and event discounts, Fellows may also apply to the Fellows All-Star Team (FAST) Accelerator to receive intensive team advising on their development and commercialization strategies.
QB3-CLSA Accelerator Membership
QB3-CLSA Accelerator membership provides all the benefits of the CLSA Fellows program as well as additional services tailored to startup operations, industry-academic partnerships and discounted QB3 events. Members of the QB3-CLSA Accelerator gain access to the collective services and resources of two of the Bay Area’s leading entrepreneur-supporting organizations.
Fellows All-Star Team (FAST) Accelerator
The FAST Advisory Program provides selected CLSA Fellows with intensive team review and coaching to perfect their business model and product development plans, and to build a compelling commercialization strategy. Experienced entrepreneurs, product and business experts (which may include clinical development, regulatory, reimbursement and business development specialists) advise the selected Fellows during a ten-to-twelve week program, culminating in a final FAST Showcase presentation to a broad audience that includes potential investors and partners.
As a member of the world’s largest international public-private partnership devoted to combatting antimicrobial resistance (AMR), the CLSI CARB-X Accelerator helps young companies in the AMR space access non-dilutive funding, entrepreneurial support and subject-matter expertise to drive innovative products into the clinic.
CLSA Partnering Days
CLSA’s Partnering Day program provides global life sciences companies and high quality, emerging firms the opportunity to participate in targeted one-on-one meetings, providing access to novel technologies for co-development. Partnering days have featured organizations including Shire, Bayer China, BMS, Novartis, Novo Nordisk, Alexion and the Leukemia & Lymphoma Society. CLSA is instrumental in attracting these organizations to participate in the Partnering Day program and in coordinating these events for members.
Fellows/Small Company Advocacy Task Force
CLSA’s Fellows/Small Company Advocacy Task Force is a platform for interested small companies to get involved in advocacy issues of importance to the life sciences industry. The Task Force helps smaller companies within CLSA’s membership stay appraised of legislation on the federal, state, and local levels; and discusses and develops positions regarding issues of particular importance to start-ups and pre-formation companies. The Task Force also is involved in CLSA policy and advocacy events, such as the annual Public Officials Receptions, and roundtables with elected officials. To learn more or join the Fellows/Small Company Advocacy Task Force, please contact Reese Isbell directly.
Find information about some of the best providers of incubator and other laboratory space in the region, helping young companies find affordable space for growth.
2016 Economic Impact Report of Bay Area Life Science Startups
Pre-Series A life science companies in the Bay Area are significantly impacting the local and state economy. This is the key finding of a survey of 137 Bay Area life science startups conducted by CLSI in Q3 of 2015. While these startups are on the leading edge of innovation in the industry, they are often not captured in traditional analyses, leaving uncovered the important economic and workforce contributions of the region’s youngest companies. As members of a vibrant and innovative life sciences cluster, these under-the-radar companies are attracting significant private and public funding, are filing and receiving patents, and creating jobs in California.